Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.3051
42.6132
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zhejiang Gongdong Medical Technology Co Ltd
Total Liabilities & Equity
Zhejiang Gongdong Medical Technology Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Zhejiang Gongdong Medical Technology Co Ltd
SSE:605369
|
Total Liabilities & Equity
ÂĄ1.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
||
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Total Liabilities & Equity
ÂĄ34.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
||
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Liabilities & Equity
ÂĄ11B
|
CAGR 3-Years
9%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Total Liabilities & Equity
ÂĄ17.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Liabilities & Equity
ÂĄ8.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
||
Intco Medical Technology Co Ltd
SZSE:300677
|
Total Liabilities & Equity
ÂĄ31.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
Zhejiang Gongdong Medical Technology Co Ltd
Glance View
Zhejiang Gongdong Medical Technology Co., Ltd. engages in the development and production of disposable medical devices and medical inspection supplies. The company is headquartered in Taizhou, Zhejiang and currently employs 1,348 full-time employees. The company went IPO on 2020-09-16. The firm's main products cover vacuum blood collection systems, laboratory testing consumables, body fluid collection consumables, medical care consumables and pharmaceutical packaging materials. Its products include disposable vacuum blood collection tubes, petri dishes, culture plates, cuvettes, pipette tips, disposable sterile sampling swabs, dispensers, dressing containers and others. The firm's products are applied in clinical diagnosis and nursing, scientific research and testing, pharmaceutical packaging and other fields. The firm distributes its products in the domestic market and to overseas markets, including many countries in North America, Asia, South America, Africa and Europe.
See Also
What is Zhejiang Gongdong Medical Technology Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
1.9B
CNY
Based on the financial report for Dec 31, 2023, Zhejiang Gongdong Medical Technology Co Ltd's Total Liabilities & Equity amounts to 1.9B CNY.
What is Zhejiang Gongdong Medical Technology Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
32%
Over the last year, the Total Liabilities & Equity growth was 1%. The average annual Total Liabilities & Equity growth rates for Zhejiang Gongdong Medical Technology Co Ltd have been 11% over the past three years , 32% over the past five years .